Oral human papillomavirus in healthy individuals: a systematic review of the literature

AR Kreimer, RK Bhatia, AL Messeguer… - Sexually transmitted …, 2010 - journals.lww.com
Background: Human papillomavirus type 16 (HPV16) is a common infection in the
anogenital tract. HPV16 DNA detected in oral specimens has recently been identified as a …

E UROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender …

AR Giuliano, AG Nyitray, AR Kreimer… - … journal of cancer, 2015 - Wiley Online Library
Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

[HTML][HTML] Evidence for single-dose protection by the bivalent HPV vaccine—review of the Costa Rica HPV vaccine trial and future research studies

AR Kreimer, R Herrero, JN Sampson, C Porras… - Vaccine, 2018 - Elsevier
Abstract The Costa Rica Vaccine Trial (CVT), a phase III randomized clinical trial, provided
the initial data that one dose of the HPV vaccine could provide durable protection against …

[HTML][HTML] Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

R Herrero, W Quint, A Hildesheim, P Gonzalez… - PloS one, 2013 - journals.plos.org
Background Human papillomavirus (HPV) infection, particularly with type 16, causes a
growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in …

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

AR Kreimer, AC Rodriguez… - Journal of the …, 2011 - academic.oup.com
Background Three-dose regimens for human papillomavirus (HPV) vaccines are expensive
and difficult to complete, especially in settings where the need for cervical cancer prevention …

[HTML][HTML] Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer

AR Kreimer, M Johansson, T Waterboer… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Purpose Human papillomavirus type 16 (HPV16) infection is causing an increasing number
of oropharyngeal cancers in the United States and Europe. The aim of our study was to …

[HTML][HTML] Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

AR Kreimer, F Struyf… - The lancet …, 2015 - thelancet.com
Background There is some evidence to suggest that one or two doses of the HPV vaccine
provides similar protection to the three-dose regimen. The main aim of the study was to …

Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study

AR Kreimer, CMP Campbell, HY Lin, W Fulp… - The Lancet, 2013 - thelancet.com
Background Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal
cancers. These cancers disproportionately affect men, are increasing in incidence, and have …

[PDF][PDF] HPV16 E7 genetic conservation is critical to carcinogenesis

L Mirabello, M Yeager, K Yu, GM Clifford, Y Xiao, B Zhu… - Cell, 2017 - cell.com
Although most cervical human papillomavirus type 16 (HPV16) infections become
undetectable within 1–2 years, persistent HPV16 causes half of all cervical cancers. We …

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

AR Kreimer, P González, HA Katki, C Porras… - The lancet …, 2011 - thelancet.com
Background Anal cancer remains rare (incidence of about 1· 5 per 100 000 women yearly),
but rates are increasing in many countries. Human papillomavirus (HPV) 16 and 18 …